Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.

[1]  J. Valencia,et al.  Premature myocardial infarction: clinical profile and angiographic findings. , 2008, International journal of cardiology.

[2]  S. Kaul,et al.  Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. , 2006, Journal of the American College of Cardiology.

[3]  J. Danesh,et al.  Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. , 2004, European heart journal.

[4]  G. Lip,et al.  Acute coronary syndromes: Virchow's triad revisited , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  W. Koenig.  Fibrin(ogen) in cardiovascular disease: an update , 2003, Thrombosis and Haemostasis.

[6]  B. Myers,et al.  The place of beta 2 glycoprotein 1 in the assessment of antiphospholipid syndrome , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.

[8]  J. Danesh,et al.  von Willebrand factor and coronary heart disease: prospective study and meta-analysis. , 2002, European heart journal.

[9]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[10]  Kathleen M. Weil,et al.  Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction , 2002, Circulation.

[11]  A. Folsom.  Hemostatic Risk Factors for Atherothrombotic Disease: An Epidemiologic View , 2001, Thrombosis and Haemostasis.

[12]  V. Salomaa,et al.  Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[13]  D. Rothenbacher,et al.  Role of novel markers of inflammation in patients with stable coronary heart disease. , 2001, The American journal of cardiology.

[14]  T. Cleophas,et al.  Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis. , 2000, The American journal of cardiology.

[15]  P. Collinson,et al.  Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. , 2000, Journal of the American College of Cardiology.

[16]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[17]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[18]  J. Foody,et al.  Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  G. Di Minno,et al.  Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[20]  H. Hahmann,et al.  The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: differences between men and women. , 1999, Atherosclerosis.

[21]  L. Weinehall,et al.  High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. , 1998, Circulation.

[22]  W. Koenig.  Haemostatic risk factors for cardiovascular diseases. , 1998, European heart journal.

[23]  A. Rumley,et al.  Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  P. Wilson,et al.  Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.

[25]  P. Ridker.  An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk. , 1995, Trends in cardiovascular medicine.

[26]  L. Chen,et al.  Clinical factors and angiographic features associated with premature coronary artery disease. , 1995, Chest.

[27]  J. Salonen,et al.  Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.

[28]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[29]  P. Elwood,et al.  Fibrin D-dimer, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study , 1998, Thrombosis and Haemostasis.

[30]  L. Tenkanen,et al.  Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. , 1995, Circulation.